The Role of Molecular Imaging in Personalised Healthcare
Functional molecular imaging provides a unique perspective on a disease. Methods including positron-emission tomography and magnetic resonance imaging allow us to interrogate spatial and temporal changes in biomarkers as well as probe the underlying biochemistry. When imaging is combined w...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | deu |
| Published: |
Swiss Chemical Society
2016-11-01
|
| Series: | CHIMIA |
| Subjects: | |
| Online Access: | https://www.chimia.ch/chimia/article/view/1844 |
| _version_ | 1819278838369091584 |
|---|---|
| author | Jason P. Holland |
| author_facet | Jason P. Holland |
| author_sort | Jason P. Holland |
| collection | DOAJ |
| description |
Functional molecular imaging provides a unique perspective on a disease. Methods including positron-emission tomography and magnetic resonance imaging allow us to interrogate spatial and temporal changes in biomarkers as well as probe the underlying biochemistry. When imaging is combined
with molecular diagnostic tools, opportunities arise for measuring aberrant cellular signalling pathways with unprecedented detail. This brief commentary illustrates how radiotracers and nuclear imaging methods are being developed to monitor drug efficacy and simultaneously support the goal of personalised healthcare.
|
| first_indexed | 2024-12-24T00:18:22Z |
| format | Article |
| id | doaj.art-9aafe7e3a9044577aa7359a52b887687 |
| institution | Directory Open Access Journal |
| issn | 0009-4293 2673-2424 |
| language | deu |
| last_indexed | 2024-12-24T00:18:22Z |
| publishDate | 2016-11-01 |
| publisher | Swiss Chemical Society |
| record_format | Article |
| series | CHIMIA |
| spelling | doaj.art-9aafe7e3a9044577aa7359a52b8876872022-12-21T17:24:40ZdeuSwiss Chemical SocietyCHIMIA0009-42932673-24242016-11-01701110.2533/chimia.2016.787The Role of Molecular Imaging in Personalised HealthcareJason P. Holland0Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. jason.holland@chem.uzh.ch Functional molecular imaging provides a unique perspective on a disease. Methods including positron-emission tomography and magnetic resonance imaging allow us to interrogate spatial and temporal changes in biomarkers as well as probe the underlying biochemistry. When imaging is combined with molecular diagnostic tools, opportunities arise for measuring aberrant cellular signalling pathways with unprecedented detail. This brief commentary illustrates how radiotracers and nuclear imaging methods are being developed to monitor drug efficacy and simultaneously support the goal of personalised healthcare. https://www.chimia.ch/chimia/article/view/1844CancerMolecular imagingOncogenic signallingPersonalised medicinePet |
| spellingShingle | Jason P. Holland The Role of Molecular Imaging in Personalised Healthcare CHIMIA Cancer Molecular imaging Oncogenic signalling Personalised medicine Pet |
| title | The Role of Molecular Imaging in Personalised Healthcare |
| title_full | The Role of Molecular Imaging in Personalised Healthcare |
| title_fullStr | The Role of Molecular Imaging in Personalised Healthcare |
| title_full_unstemmed | The Role of Molecular Imaging in Personalised Healthcare |
| title_short | The Role of Molecular Imaging in Personalised Healthcare |
| title_sort | role of molecular imaging in personalised healthcare |
| topic | Cancer Molecular imaging Oncogenic signalling Personalised medicine Pet |
| url | https://www.chimia.ch/chimia/article/view/1844 |
| work_keys_str_mv | AT jasonpholland theroleofmolecularimaginginpersonalisedhealthcare AT jasonpholland roleofmolecularimaginginpersonalisedhealthcare |